Bioinformatics combined with stable-isotope labeling helps identify orphan gene products in bacteria. A major challenge of the genomic era is how best to use the immense and growing body of ...
In a groundbreaking discovery, researchers have identified a novel orphan gene, BOLTING RESISTANCE 2 (BR2), in Chinese cabbage, which plays a pivotal role in delaying bolting by regulating ...
AccurEdit Therapeutics today announced that its innovative in vivo gene editing product, ART001, has obtained Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA).
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...
Hosted on MSN1mon
FDA grants orphan drug status to Arbor Biotechnologies’ PH1The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation (RPDD) to Arbor Biotechnologies' gene editing therapeutic, ABO-101 ...
a leading biopharmaceutical company for cell and gene therapy CDMO and novel drug development, announced today that its investigational drug EN001 has been granted Orphan Drug Designation (ODD ...
Orphan drug designation is granted by the FDA ... Our platform combines class-leading proprietary base editing and high-efficiency gene integration systems with high-capacity virus-like particles ...
Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback